Pharma for Obama, but neither candidate loves pharma

While drug companies have donated about $450,000 to the Obama campaign, they've only given McCain a little over $132,000.  Interestingly, this is the opposite of what we saw in the Bush-Kerry election, where the republican candidate received almost twice as much as the democrat.

For their parts, both candidates strongly support generics, including getting them to market faster and promoting their inclusion in trade agreements with developing countries. McCain and Obama both also support government negotiation of medications included in Medicare plans, re-importation and price controls - which neither big pharma nor biotech companies are likely to appreciate.  

- the story at Medical Marketing & Media
- see more at CNBC

Suggested Articles

Amgen could soon face new competition in the PCSK9 class, but an efficacy boost in treating high-risk heart attack patients could help keep it ahead.

In its quest to become the dominant SGLT2 diabetes med for heart failure, Jardiance is touting DPP-4 inhibitor-topping data to support its case.

Despite having lost some of its novelty, AZ's Brilinta is touting bleeding data over aspirin that could be a big break in acute coronary syndrome.